225 related articles for article (PubMed ID: 16321441)
1. The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes.
Zhang Y; Yang XD; Wang K; Crans DC
J Inorg Biochem; 2006 Jan; 100(1):80-7. PubMed ID: 16321441
[TBL] [Abstract][Full Text] [Related]
2. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
3. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Bergeron A; Kostenkova K; Selman M; Murakami HA; Owens E; Haribabu N; Arulanandam R; Diallo JS; Crans DC
Biometals; 2019 Jun; 32(3):545-561. PubMed ID: 31209680
[TBL] [Abstract][Full Text] [Related]
5. The permeability and cytotoxicity of insulin-mimetic vanadium compounds.
Yang XG; Yang XD; Yuan L; Wang K; Crans DC
Pharm Res; 2004 Jun; 21(6):1026-33. PubMed ID: 15212169
[TBL] [Abstract][Full Text] [Related]
6. 51V solid-state NMR and density functional theory studies of vanadium environments in V(V)O2 dipicolinic acid complexes.
Bolte SE; Ooms KJ; Polenova T; Baruah B; Crans DC; Smee JJ
J Chem Phys; 2008 Feb; 128(5):052317. PubMed ID: 18266434
[TBL] [Abstract][Full Text] [Related]
7. Effect of the chloro-substitution on lowering diabetic hyperglycemia of vanadium complexes with their permeability and cytotoxicity.
Xie MJ; Niu YF; Yang XD; Liu WP; Li L; Gao LH; Yan SP; Meng ZH
Eur J Med Chem; 2010 Dec; 45(12):6077-84. PubMed ID: 21036421
[TBL] [Abstract][Full Text] [Related]
8. Correlation of insulin-enhancing properties of vanadium-dipicolinate complexes in model membrane systems: phospholipid langmuir monolayers and AOT reverse micelles.
Sostarecz AG; Gaidamauskas E; Distin S; Bonetti SJ; Levinger NE; Crans DC
Chemistry; 2014 Apr; 20(17):5149-59. PubMed ID: 24615733
[TBL] [Abstract][Full Text] [Related]
9. Aerobic oxidation of pinacol by vanadium(V) dipicolinate complexes: evidence for reduction to vanadium(III).
Hanson SK; Baker RT; Gordon JC; Scott BL; Sutton AD; Thorn DL
J Am Chem Soc; 2009 Jan; 131(2):428-9. PubMed ID: 19140782
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of the insulin-mimetic behaviour of vanadium(IV, V) coordination compounds.
Rehder D; Costa Pessoa J; Geraldes CF; Castro MC; Kabanos T; Kiss T; Meier B; Micera G; Pettersson L; Rangel M; Salifoglou A; Turel I; Wang D
J Biol Inorg Chem; 2002 Apr; 7(4-5):384-96. PubMed ID: 11941496
[TBL] [Abstract][Full Text] [Related]
11. Bis(maltolato)vanadium(III)-polypyridyl complexes: synthesis, characterization, DNA cleavage, and insulin mimetic activity.
Islam MN; Kumbhar AA; Kumbhar AS; Zeller M; Butcher RJ; Dusane MB; Joshi BN
Inorg Chem; 2010 Sep; 49(18):8237-46. PubMed ID: 20715814
[TBL] [Abstract][Full Text] [Related]
12. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
13. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
14. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
15. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
16. Redox chemistry in thin layers of organometallic complexes prepared using ion soft landing.
Peng WP; Johnson GE; Fortmeyer IC; Wang P; Hadjar O; Cooks RG; Laskin J
Phys Chem Chem Phys; 2011 Jan; 13(1):267-75. PubMed ID: 21076748
[TBL] [Abstract][Full Text] [Related]
17. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
Lee PK; Law WH; Liu HW; Lo KK
Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
[TBL] [Abstract][Full Text] [Related]
18. Vanadium(IV/V) complexes of Triapine and related thiosemicarbazones: Synthesis, solution equilibrium and bioactivity.
Kowol CR; Nagy NV; Jakusch T; Roller A; Heffeter P; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2015 Nov; 152():62-73. PubMed ID: 26349014
[TBL] [Abstract][Full Text] [Related]
19. An approach to As(III) and As(V) bioavailability studies with Caco-2 cells.
Laparra JM; Vélez D; Barberá R; Montoro R; Farré R
Toxicol In Vitro; 2005 Dec; 19(8):1071-8. PubMed ID: 16023827
[TBL] [Abstract][Full Text] [Related]
20. Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.
Kanamori K; Nishida K; Miyata N; Shimoyama T; Hata K; Mihara C; Okamoto K; Abe Y; Hayakawa S; Matsugo S
Inorg Chem; 2004 Nov; 43(22):7127-40. PubMed ID: 15500351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
